Skip to main content
  • Home
  • About Us
  • Advisory Board
  • Advertise
  • Editorial Submissions
  • Contact Us
  • Subscribe to Newsletter

  • Follow me on Twitter
  • Friend me on Facebook
  • Connect with me on LinkedIn
  • Subscribe to me on YouTube
  • Subscribe to my RSS Feed

Menu

Skip to content
  • MedTech Economics
  • Policy
  • Manufacturing Execution
  • Product Design & Development
  • Quality & Compliance
  • Digital Health
  • Resource Library
  • Events & Webinars

MedTech Economics

Home Health
December 5, 2024
Home Health

Connected and personalized care revolutionize home healthcare

By MedTech Intelligence Staff

The integration of technology and connectivity into healthcare is not only improving patient outcomes but also reshaping the way care is delivered.

Continue reading →

December 5, 2024

6 Cardiovascular Technologies to Watch in 2025

By Emily Newton

Cardiovascular conditions are the leading cause of death. Fortunately, industry leaders are discovering innovative ways to diagnose and treat them. See how mobile apps and AI will change this field in 2025 and beyond.

Continue reading →

November 8, 2024

Trinity Biotech: Regains Compliance with Nasdaq Listing Requirements

Trinity received written notice from the Nasdaq Stock Market LLC (“Nasdaq”) confirming that the Company has regained compliance with the minimum market value of publicly held shares required.

Continue reading →

medical device scrutiny
August 16, 2024
medical device scrutiny

Soaring Medical Device Scrutiny: How is the Market Adapting?

In the light of new research, Peter Muller and Mike Baird of Schlafender Hase assess how well Class 2 and 3 device manufacturers in Europe and the US are adapting to a rise in regulatory controls.

Continue reading →

EU Commission
August 6, 2024
EU Commission

Q2/2024 Life Science Law Update: Key developments for pharma & device companies in EU

Q2/24 Life Science and Health Care Law Updates by Hogan Lovells including key trends in the EU and Big Five (France, Germany, Italy, Spain, UK) regulatory, corporate, compliance, competition, and privacy.

Continue reading →

FDA
July 18, 2024
FDA

Safe harbor for voluntary corrections of drug or device “misinformation” clarified in FDA guidance

By Hogan Lovells Engage

Law firm, Hogan Lovells, analyzes the changes to the updated enforcement policy and provide key takeaways for entities responsible for communication regarding approved/cleared medical products.

Continue reading →

EU Commission
July 17, 2024
EU Commission

Implications of the EU AI Act on medtech companies

By Hogan Lovells Engage

Law firm, Hogan Lovells, analyses the implications of the AI Act for the Medtech sector and highlight a number of key challenges for medical device manufacturers and their partners in aligning conformity routes for their products under the AI Act.

Continue reading →

Smith+Nephew logo
July 8, 2024
Smith+Nephew logo

Smith & Nephew shares surge on activist Cevian building stake

By MedTech Intelligence Staff

Cevian Capital increased its position in Smith & Nephew to a 5% stake in the British medical equipment maker, making it Smith & Nephew’s second largest shareholder according to reports by Reuters.

Continue reading →

Farida Ali
July 6, 2023
Farida Ali
Soapbox

Managing the Post-Pandemic Pricing Squeeze

By Farida Ali

As technology component pricing continues to rise, MedTech manufacturers are applying proven methods and exploring new approaches to maintain profitability and extend product lifecycles.

Continue reading →

Michael Marquardt
May 3, 2023
Michael Marquardt

Implementing MedTech Price Increases in Times of Inflation and EU MDR

By Michael Marquardt

Medical technology companies are caught between rising costs and increasing inflation as well as stricter regulations due to the introduction of the EU Medical Device Regulation. A strategic price adjustment can help to face these challenges and secure the companies’ success in the long term.

Continue reading →

Post navigation

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 36
  • Next

Upcoming Events & Webinars

No posts found.



On Demand Events & Webinars

No posts found.






Columns

April 20, 2026

Styker Adds IVL Technology to Peripheral Vascular Portfolio with Amplitude Acquisition

By MedTech Intelligence Staff
Stryker

Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio

April 17, 2026

The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators

By Melissa Corneal

Traditionally, contract negotiation has been viewed as a financial or legal responsibility, typically led by finance teams, legal counsel, or executive leadership, with operations stepping in afterward to execute against decisions that have already been made, but that model is evolving as healthcare delivery becomes more interconnected and operationally complex, requiring administrators to engage earlier in the process, not only to understand what is being agreed to but to help define how those agreements will function in real-world environments.

March 27, 2026

Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows

By MedTech Intelligence Staff

What we’re reading on LinkedIn… Review of leading healthcare AI reports illustrate several conditions creating fertile ground for applied AI in healthcare operations.

March 20, 2026

Mindray North America Enters Ventilator Market

By MedTech Intelligence Staff

Mindray says its entry into the ventilator market marks a significant step in expanding advanced respiratory care options for clinicians and patients, reinforcing the medical device leader’s commitment to driving innovation in healthcare.

March 20, 2026

LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea

By MedTech Intelligence Staff

Hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning language. The next-generation, MRI-compatible device is expected to launch in the first half of 2027, pending FDA supplement review.

March 20, 2026

EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization

By MedTech Intelligence Staff
EPA Logo

The medical device industry and EPA have been in ongoing debate over balancing the need for sterile medical equipment with concerns about pollution near sterilization plants.

March 18, 2026

Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia

Prodeon Medical

The Urocross Expander System is designed to remodel the obstructing prostatic lobes during the six-month indwell time and is intentionally retrieved, leaving no permanent foreign material behind.

March 18, 2026

JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)

By MedTech Intelligence Staff
JenaValve

With its FDA approval, JenaValve intends to commence launch activity for the Trilogy System immediately with participating clinical study sites.

TOPICS

  • Digital Health
  • MedTech Economics
  • Manufacturing Execution
  • Product Design & Development
  • Quality/Regulatory

Upcoming Events & Webinars

No posts found.

Contact Us

  • Advertising Opportunities
  • Editorial Submissions
  • General Inquiries
  • Privacy Policy
  • Cookie Policy
  • Sign Up for Newsletters

Innovative Publishing Company, Inc.

  • FoodSafetyTech
  • Food Safety Consortium Conference & Expo
  • MedTech Intelligence
  • Cannabis Industry Journal

© Copyright 2015 - 2026 Innovative Publishing Co., Inc., All Rights Reserved

Other Innovative Publishing Co., Inc. Sites: Food Safety Tech  |  Cannabis Industry Journal

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

MedTech Intelligence
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

We use tracking pixels that set your arrival time at our website, this is used as part of our anti-spam and security measures. Disabling this tracking pixel would disable some of our security measures, and is therefore considered necessary for the safe operation of the website. This tracking pixel is cleared from your system when you delete files in your history.

We also use cookies to store your preferences regarding the setting of 3rd Party Cookies.

Cookie Policy

A browser cookie is a small piece of data that is stored on your device to help websites and mobile apps remember things about you. Other technologies, including Web storage and identifiers associated with your device, may be used for similar purposes. In this policy, we say “cookies” to discuss all of these technologies.

Our Privacy Policy explains how we collect and use information from and about you when you use This website and certain other Innovative Publishing Co LLC services. This policy explains more about how we use cookies and your related choices.

How We Use Cookies

Data generated from cookies and other behavioral tracking technology is not made available to any outside parties, and is only used in the aggregate to make editorial decisions for the websites. Most browsers are initially set up to accept cookies, but you can reset your browser to refuse all cookies or to indicate when a cookie is being sent by visiting this Cookies Policy page. If your cookies are disabled in the browser, neither the tracking cookie nor the preference cookie is set, and you are in effect opted-out.

In other cases, our advertisers request to use third-party tracking to verify our ad delivery, or to remarket their products and/or services to you on other websites. You may opt-out of these tracking pixels by adjusting the Do Not Track settings in your browser, or by visiting the Network Advertising Initiative Opt Out page.

You have control over whether, how, and when cookies and other tracking technologies are installed on your devices. Although each browser is different, most browsers enable their users to access and edit their cookie preferences in their browser settings. The rejection or disabling of some cookies may impact certain features of the site or to cause some of the website’s services not to function properly.

Individuals may opt-out of 3rd Party Cookies used on IPC websites by adjusting your cookie preferences through this Cookie Preferences tool, or by setting web browser settings to refuse cookies and similar tracking mechanisms. Please note that web browsers operate using different identifiers. As such, you must adjust your settings in each web browser and for each computer or device on which you would like to opt-out on. Further, if you simply delete your cookies, you will need to remove cookies from your device after every visit to the websites. You may download a browser plugin that will help you maintain your opt-out choices by visiting www.aboutads.info/pmc. You may block cookies entirely by disabling cookie use in your browser or by setting your browser to ask for your permission before setting a cookie. Blocking cookies entirely may cause some websites to work incorrectly or less effectively.

The use of online tracking mechanisms by third parties is subject to those third parties’ own privacy policies, and not this Policy. If you prefer to prevent third parties from setting and accessing cookies on your computer, you may set your browser to block all cookies. Additionally, you may remove yourself from the targeted advertising of companies within the Network Advertising Initiative by opting out here, or of companies participating in the Digital Advertising Alliance program by opting out here.